Good MorningU.S. stocks finished mixed Wednesday, with the S&P 500 and Nasdaq 100 slipping into negative territory after giving up early gains. Technology shares were uneven as AI-related optimism competed with renewed valuation concerns. NVIDIA rose after Elon Musk said SpaceX would exclusively buy its chips, while shares of SpaceX and AMD declined.
Earnings continued to drive sharp individual-stock moves. AppLovin fell following mixed second-quarter results and a softer-than-expected third-quarter outlook. Western Digital and SanDisk also declined despite earnings beats, while HubSpot, E.l.f. Beauty and Axon fell after their reports. IonQ rose after beating estimates and raising its 2026 outlook, while Block advanced following a quarterly beat.
Energy and geopolitical developments remained in focus as Iran announced a Strait of Hormuz plan and calls for a deal prompted investor caution. Higher oil prices supported several producers: Devon Energy beat estimates on stronger output and pricing, while Kinetik posted record results and raised full-year guidance. Corporate actions included Celestica’s planned $3 billion equity offering to fund AI-infrastructure growth, while Darling Ingredients authorized a $1 billion share-repurchase program. Featured: RIP USD (Ad) 
|
Communication Services | |
SpaceX (NASDAQ: SPCX) is a great company to follow and love, being well-positioned in the global race to commercialize space. It provides numerous opportunities for humanity and investors, but now may not be the best time to buy the stock.
Still suffering from its post-IPO malaise, the market show... Read the Full Story |
|
From Our Partners | | 232 companies listed on U.S. exchanges this year, raising over $251 billion by late July alone - more than five times 2025's full-year total. Yet most carry almost no analyst coverage.
We screened the entire class for average daily volume above 500,000 shares, market caps over $100 million, and at least 18 months of cash runway. Only seven names cleared every filter - four already trading, three still private. | | See the seven IPOs that passed every filter. |
|
Consumer Discretionary | |
Ulta Beauty (NASDAQ: ULTA) has proven to Wall Street that it can grow faster than expected. Now it needs to convince investors to stop worrying.
The beauty retailer has spent years proving to be one of the steadier growth stories in the discretionary retail sector. Its latest quarter did little to... Read the Full Story |
|
Industrials | |
The artificial intelligence (AI) revolution is running into a severe physical roadblock: the electrical grid. Data centers consume extraordinary amounts of electricity, and tech giants are scrambling to secure reliable, carbon-free baseload power. Wind and solar lack the consistency required to run... Read the Full Story |
|
From Our Partners | | One tanker operator's vessels now earn $51,870 a day, up from $21,000 before the war, against a $10,800 breakeven.
That surge pushed Robert Kiyosaki to add this tanker and four more positions to his Perpetual Income Plan, raising its payout schedule from 42 to 74 times a year. | | Watch the video revealing all five new income positions now |
|
Communication Services | |
Meta Platform’s (NASDAQ: META) Q2 earnings distinctly disappointed investors, as demonstrated by the stock’s 8% fall after the report.
Wall Street analysts did not react well to the report either, with many issuing substantial price target decreases afterward.
These decreases were also more signif... Read the Full Story |
|
Technology | |
Contrarian as it may sound, Advanced Micro Devices' (NASDAQ: AMD) August price pullback looks like a strong signal to buy. The pullback was triggered by a typically understated earnings report and lofty expectations; however, nothing in the release warranted closing out positions or shorting the st... Read the Full Story |
|
From Our Partners | | Moderna shares surged almost 200% in a single day after a successful phase 3 trial for its cancer drug, while Merck added $43 billion in market cap on the same news.
Porter & Co. has already guided readers to gains of 237% on uniQure, 206% on Sagimet Biosciences, and 156% on TG Therapeutics - six of the firm's top ten performing positions are in biotech. | | Watch the Ignition Point broadcast to see our next biotech pick |
|
Technology | |
Everyone has already made money on the AI buildout. The next money gets made by whoever's actually using it.
For the past two years, the easiest trades in the market were the ones tied directly to AI infrastructure: the chips, the data centers, the power contracts. That money has largely been made.... Read the Full Story |
|
Healthcare | |
As the rotation out of high-flying tech stocks continues, the healthcare sector has been a major beneficiary. Over the past three months, that corner of the market has been one of the strongest performers among the S&P 500’s 11 sectors with a nearly 12% gain.
Hims & Hers Health (NYSE: HIMS)... Read the Full Story |
|
Materials | |
Concentration in a relatively small number of mega-cap stocks, inflation, elevated oil and gas prices, and other concerns have not been enough to stop the S&P 500's bull run in the first half of 2026. Buoyed by strong corporate earnings and capital spending on AI-related projects, the economy h... Read the Full Story |
|
Consumer Staples | |
Archer-Daniels-Midland (NYSE: ADM) delivered one of its strongest quarters in years before the market opened on Aug. 4. But out of the gate, ADM only gained about 1%. The muted reaction could be due to valuation concerns. ADM is up over 35% in 2026, and a nuance in the report could be giving invest... Read the Full Story |
|
Technology | |
Institutional capital is aggressively rotating out of legacy software and flooding into the physical backbone of the artificial intelligence (AI) economy. Sitting at a market capitalization that hovers around $41.7 billion, CoreWeave (NASDAQ: CRWV) represents a direct opportunity in this monumental... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York. | Should I Buy International Business Machines Stock? IBM Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of International Business Machines was last updated on Monday, November 02, 2026 at 6:26 PM.
International Business Machines Bull Case -
International Business Machines Co. recently reported strong third-quarter results on October 21, 2026, beating analyst expectations with earnings per share of $2.95 compared to the consensus estimate of $2.85, while also exceeding revenue forecasts with $17.10 billion in sales against an expected $16.82 billion, demonstrating robust operational performance and profitability with a net margin of 15.99%.
-
The company offers a compelling income opportunity with a dividend yield of 2.62%, supported by a recent quarterly dividend announcement of $1.69 per share to be paid on December 10, 2026, which provides a steady cash flow for income-focused investors despite a payout ratio of 57.63%.
-
Wall Street maintains a positive outlook on the stock, with a consensus rating of "Moderate Buy" and an average price target of $266.12 as of October 31, 2026, which suggests potential upside from the current trading levels and reflects confidence in the company's hybrid cloud and AI strategy.
-
International Business Machines Co. exhibits lower volatility compared to the broader market with a beta of 0.78, making it a potentially stable holding for investors seeking to reduce portfolio risk while still participating in the growth of the technology sector.
-
The stock is currently trading at $252.98, which is below its 52-week high of $332.46, presenting a potential entry point for long-term investors who believe in the company's strategic positioning in enterprise software and consulting services.
International Business Machines Bear Case -
The stock has experienced a recent decline, trading down 1.9% to $252.98 on November 2, 2026, and has fallen below its 200-day moving average of $249.93, indicating short-term technical weakness and potential downward momentum in the near term.
-
International Business Machines Co. carries a significant debt load with a debt-to-equity ratio of 1.57, which may limit financial flexibility and increase risk during periods of economic uncertainty or rising interest rates, despite its strong cash flow generation.
-
Recent insider activity includes a substantial sale by Senior Vice President Robert Thomas, who sold 25,000 shares on August 26, 2026, reducing his ownership by 34.34%, which could signal a lack of confidence from company leadership or a desire to diversify personal holdings.
-
The company's liquidity position is somewhat constrained with a current ratio of 0.85 and a quick ratio of 0.80, both below 1.0, suggesting that current liabilities exceed current assets, which could pose challenges in meeting short-term obligations without additional financing.
-
While the consensus price target is $266.12, some analysts have recently lowered their targets, such as HSBC reducing its target from $175.00 to $174.00 in July 2026, indicating that there is still significant disagreement among Wall Street firms regarding the stock's fair value and future growth potential.
| | View Today's Stock Pick |
|
